ARNOLD & PORTER KAYE SCHOLER LLP for LIEBER INSTITUTE FOR BRAIN DEVELOPMENT
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Engagement on FY23 L-HHS Appropriations (H.R. 8295/S. 4659) Congressional Directed Spending requests related to diagnostic and drug discovery to improve health outcomes for African Americans, and engagement on FY24 appropriations requests related to furthering Liebers mission of understanding the genetic and molecular mechanisms behind schizophrenia and brain disorders to improve the lives of all individuals affected by such conditions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CASEY BROUHARD | — |
| DOROTHY ISGUR New | — |
| KEVIN MICHAEL O'NEILL | — |
| EUGENIA PIERSON | — |
| NATALIE TIETJEN New | Intern, Rep. Watson Coleman (2018) |
Medical/Disease Research/Clinical Labs MED
Engagement with the Department of Energy (DOE) relating to accessing the agency's supercomputers for the purpose of conducting research on brain disorders.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KRISTINE BLACKWOOD | — |
| CASEY BROUHARD | — |
| DOROTHY ISGUR New | — |
| KEVIN MICHAEL O'NEILL | — |
| EUGENIA PIERSON | — |
| NATALIE TIETJEN New | Intern, Rep. Watson Coleman (2018) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.